Sanofi (SNY) Current Taxes (2015 - 2025)
Sanofi (SNY) posted Current Taxes of $874.2 million for Q4 2025, up 6.67% sequentially from $819.5 million in Q2 2025, and up 17.37% YoY from $744.8 million in Q4 2024.
Sanofi (SNY) Current Taxes (2015 - 2025) Analysis & Trends
Sanofi (SNY) has 11 years of Current Taxes data on file, last reported at $874.2 million in Q4 2025.
- Quarterly Current Taxes rose 17.37% year-over-year to $874.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $874.2 million (up 17.37% YoY) and the FY2025 annual result came in at $874.2 million, up 17.37% from the prior year.
- Current Taxes improved to $874.2 million in Q4 2025 per SNY's latest filing, from $819.5 million in the prior quarter.
- The five-year high for Current Taxes was $874.2 million in Q4 2025, with the low at $142.1 million in Q2 2024.
- Average Current Taxes over 5 years is $575.3 million, with a median of $614.0 million recorded in 2023.
- Year-over-year, Current Taxes slumped 65.37% in 2024 and jumped 476.53% in 2025.
- Sanofi's Current Taxes stood at $353.5 million in 2021, then surged by 65.67% to $585.6 million in 2022, then gained by 9.68% to $642.3 million in 2023, then gained by 15.95% to $744.8 million in 2024, then gained by 17.37% to $874.2 million in 2025.
- Business Quant data shows SNY's Current Taxes at $874.2 million in Q4 2025, $819.5 million in Q2 2025, and $744.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 1.09 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -1.30 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 3.95 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 3.13 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Sanofi | - | - | 9.49 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 874.20 Mn |
| Jun 30, 2025 | 819.54 Mn |
| Dec 31, 2024 | 744.81 Mn |
| Jun 30, 2024 | 142.15 Mn |
| Dec 31, 2023 | 642.34 Mn |
| Jun 30, 2023 | 410.52 Mn |
| Dec 31, 2022 | 585.62 Mn |
| Jun 30, 2022 | 472.71 Mn |
| Dec 31, 2021 | 353.49 Mn |
| Jun 30, 2021 | 708.11 Mn |
| Dec 31, 2020 | 720.14 Mn |
| Dec 31, 2019 | 285.58 Mn |
| Dec 31, 2018 | 447.43 Mn |
| Dec 31, 2017 | 1.39 Bn |
| Dec 31, 2016 | 1.22 Bn |
| Dec 31, 2015 | 1.14 Bn |